Disclosures for "Implications for Age and Sex Differences on Anti-Hyperglycemic Therapy Exposure and Incidence of Newly Diagnosed Multiple Sclerosis in Propensity Score Matched Type 2 Diabetics")
-
Mr. Branigan has nothing to disclose.
-
Miss Torrandell Haro has nothing to disclose.
-
Francesca Vitali has nothing to disclose.
-
Roberta Diaz Brinton, PhD has nothing to disclose.
-
Kathleen Rodgers has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Proneurogen. Kathleen Rodgers has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Regulonix. Kathleen Rodgers has received intellectual property interests from a discovery or technology relating to health care.